About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD

NCT02542826·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Dennis Jensen, Ph.D.
CONTACT
514-398-4184 dennis.jensen@mcgill.ca

Lead

McGill University

With

Mount Sinai Hospital, Montreal
Laval University

Age

40–80

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Male or Female
Ambulatory
Moderate-to-very severe COPD (GOLD Stage 2-4)

You may not be if

Respiratory exacerbation in the previous 6 weeks
Change in medication dosage/frequency in the previous 6 weeks
Clinical evidence of asthma
Cardiovascular and/or neuromuscular diseases that are unstable and/or that may contribute to exercise limitation
Any other contraindications to exercise training/testing

The record

StatusUnknown

PhaseNo phase

Taking part80

StartedAug 2015

UpdatedFeb 14, 2017

Conditions

Pulmonary Disease, Chronic Obstructive

Where1

McConnell Centre for Innovative Medicine, Research Institute of the McGill University Health Centre
Montreal, Quebec, Canada

Clareo Health | Pulmonary Rehab, Dyspnea, Walk and Step Testing in COPD